K. Erturk Et Al. , "Clinical significance of serum protease activated receptor1 levels in patients with lung cancer," European Review for Medical and Pharmacological Sciences , vol.20, no.2, pp.243-249, 2016
Erturk, K. Et Al. 2016. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer. European Review for Medical and Pharmacological Sciences , vol.20, no.2 , 243-249.
Erturk, K., Tastekin, D., Bilgin, E., Tas, F., Disci, R., & Duranyildiz, D., (2016). Clinical significance of serum protease activated receptor1 levels in patients with lung cancer. European Review for Medical and Pharmacological Sciences , vol.20, no.2, 243-249.
Erturk, K. Et Al. "Clinical significance of serum protease activated receptor1 levels in patients with lung cancer," European Review for Medical and Pharmacological Sciences , vol.20, no.2, 243-249, 2016
Erturk, K. Et Al. "Clinical significance of serum protease activated receptor1 levels in patients with lung cancer." European Review for Medical and Pharmacological Sciences , vol.20, no.2, pp.243-249, 2016
Erturk, K. Et Al. (2016) . "Clinical significance of serum protease activated receptor1 levels in patients with lung cancer." European Review for Medical and Pharmacological Sciences , vol.20, no.2, pp.243-249.
@article{article, author={K. Erturk Et Al. }, title={Clinical significance of serum protease activated receptor1 levels in patients with lung cancer}, journal={European Review for Medical and Pharmacological Sciences}, year=2016, pages={243-249} }